Inspire Medical Systems, Inc. (NYSE: INSP) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $260.00 price target on the stock.
LowReport
Inspire Medical Systems, Inc. (NYSE: INSP) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $260.00 price target on the stock.
Inspire Medical Systems, Inc. (NYSE: INSP) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $260.00 price target on the stock, up previously from $255.00.
LowReport
Inspire Medical Systems, Inc. (NYSE: INSP) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $260.00 price target on the stock, up previously from $255.00.
Inspire Medical Systems, Inc. (NYSE: INSP) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $200.00 price target on the stock, up previously from $170.00.
LowReport
Inspire Medical Systems, Inc. (NYSE: INSP) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $200.00 price target on the stock, up previously from $170.00.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: